Transcutaneous electrical nerve stimulation (TENS) is a noninvasive modality used to control pain. Animal models show that repeated TENS application produces analgesic tolerance and cross-tolerance at spinal opioid receptors. The aim of the present investigation was to examine whether repeated application of TENS produces analgesic tolerance in humans. One hundred healthy subjects were randomly assigned to 1 of 4 groups: control, placebo, low-frequency (4 Hz) or high-frequency (100 Hz) TENS. TENS was applied daily for 5 days to the nondominant upper limb; pressure-pain threshold (PPT) measurements were recorded before and after TENS. Temporal summation to mechanical stimulation was recorded on days 1 and 5, before and after TENS. Diffuse noxious inhibitory control (DNIC) was tested on day 5 using the cold pressor test and PPT measurements. There was an initial increase in PPTs in both low-and high-frequency TENS groups when compared with placebo or control groups. However, by day 5 this TENS-induced increase in PPT did not occur, and there was no difference between active TENS and placebo or control groups. High-frequency TENS decreased temporal summation on day 1 when compared with day 5. DNIC increased the PPT similarly in all groups. These data suggest that repeated daily application of TENS results in a decrease in its hypoalgesic effect by the fifth day and that the tolerancelike effect to repeated TENS results from tolerance at centrally located opioid receptors. The lack of change in DNIC response suggests that TENS and DNIC utilize separate pathways to produce analgesia. Ó
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Transcutaneous electrical nerve stimulation (TENS) is a noninvasive modality used to control pain. Animal models show that repeated TENS application produces analgesic tolerance and cross-tolerance at spinal opioid receptors. The aim of the present investigation was to examine whether repeated application of TENS produces analgesic tolerance in humans. One hundred healthy subjects were randomly assigned to 1 of 4 groups: control, placebo, low-frequency (4 Hz) or high-frequency (100 Hz) TENS. TENS was applied daily for 5 days to the nondominant upper limb; pressure-pain threshold (PPT) measurements were recorded before and after TENS. Temporal summation to mechanical stimulation was recorded on days 1 and 5, before and after TENS. Diffuse noxious inhibitory control (DNIC) was tested on day 5 using the cold pressor test and PPT measurements. There was an initial increase in PPTs in both low-and high-frequency TENS groups when compared with placebo or control groups. However, by day 5 this TENS-induced increase in PPT did not occur, and there was no difference between active TENS and placebo or control groups. High-frequency TENS decreased temporal summation on day 1 when compared with day 5. DNIC increased the PPT similarly in all groups. These data suggest that repeated daily application of TENS results in a decrease in its hypoalgesic effect by the fifth day and that the tolerancelike effect to repeated TENS results from tolerance at centrally located opioid receptors. The lack of change in DNIC response suggests that TENS and DNIC utilize separate pathways to produce analgesia.
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Introduction
Transcutaneous electrical nerve stimulation (TENS) involves the application of electrical currents to the skin for pain control; it is a noninvasive modality that is commonly used by health care professionals to control both acute and chronic pain arising from several conditions Repeated stimulation of opioid receptors by repeated administration of morphine or opioid analgesics can lead to an analgesic tolerance, defined as a decrease in analgesic effectiveness with repeated use [43] . In a similar way, repeated utilization of therapeutic electrophysical agents that reduce pain through release of endogenous opioids could have a gradual diminution of their analgesic effect. Chandran and Sluka [9] demonstrated in rats that repeated administration of low-and high-frequency TENS leads to a development of opioid tolerance with a corresponding cross-tolerance to intrathecally administered l-and d-opioid agonists, respectively. In clinical practice, TENS is usually applied daily over many weeks. Approximately 30% of patients fail to respond to TENS and, of the patients who respond initially, only one third continue to obtain pain relief after 2 years [4] . Solomon et al. [63] showed that people who had been taking opioids long enough to develop tolerance before surgery did not respond to TENS when used postoperatively. Although commonly accepted that TENS reduces its efficacy with repeated application, the development of tolerance to TENS has not been investigated and confirmed in human subjects. With these concerns in mind, the aim of the present investigation was to examine the analgesic tolerance to TENS in human subjects.
